Earnings calendar/BCAX
Bicara Therapeutics Inc. Common Stock (BCAX)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 9, 2026
Consensus estimate row
EPS target
$-0.85
Street estimate
Revenue target
—
Street estimate
Trailing EPS (avg 4Q)
$-0.78
Beat rate last 4: 25%
Latest EPS YoY
-64.0%
vs 2025-08-12
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
—
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 11, 2026
EPS miss
EPS actual / est
$-0.82 / $-0.82
-0.0%
Revenue actual / est
— / —
—
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/9/2026upcoming | $-0.85 | Pending | — | — | Pending | — |
| 8/11/2026 | $-0.82 | $-0.82 | -0.0% | — | Pending | — |
| 5/12/2026upcoming | $-0.64 | Pending | — | — | Pending | — |
| 5/11/2026 | $-0.64 | $-0.93 | -45.3% | — | Pending | — |
| 3/30/2026upcoming | $-0.72 | Pending | — | — | Pending | — |
| 3/26/2026 | $-0.72 | $-0.68 | +5.6% | — | Pending | — |
| 11/10/2025 | $-0.55 | $-0.67 | -21.8% | — | Pending | — |
| 8/12/2025 | $-0.54 | $-0.50 | +7.4% | — | Pending | — |
| 5/13/2025 | $-0.40 | $-0.68 | -70.0% | — | Pending | — |
| 3/27/2025 | $-0.31 | $-0.39 | -25.8% | — | Pending | — |
| 11/12/2024 | $-0.46 | $-1.60 | -247.8% | — | Pending | — |
| 9/13/2024 | — | $-0.45 | — | — | Pending | — |
| 6/30/2024 | — | $-0.27 | — | — | Pending | — |
| 12/31/2023 | — | $-0.23 | — | — | Pending | — |
| 9/30/2023 | — | $-0.42 | — | — | Pending | — |
| 6/30/2023 | — | $-0.15 | — | — | Pending | — |
| 3/31/2023 | — | $-0.15 | — | — | Pending | — |